|
Factores
asociados a severidad VRS |
Bronquiolitis |
|
Hospitalizaciones a VRS
en menores de 24 meses |
Protocolo Bronquiolitis
Soc Española CIP |
|
Early Life RSV:
Can Vaccines Help Fix Societal Ills? |
Diagnóstico y manejo de Bronquiolitis |
|
Risk factors in
children hospitalized with RSV bronchiolitis |
Cánula nasal de alto flujo |
|
Respiratory
Syncytial Virus-Associated Hospitalizations |
Protocolo CNAF Hosp
Puerto Montt |
|
VRS -Associated
Outpatient Visits Among Children |
Protocolo CNAF Hosp Calvo Mackenna |
|
Viral Loads and Severity in Young Children With VRS |
Ventilación No invasiva en falla respiratoria pediátrica |
|
Coronavirus Clinical
and Respiratory Syncytial
Virus |
VRS activity 2021 |
|
VRS-attributable Deaths in a Major Pediatric Hospital |
Innate Immune Dysfunction and Severe Bronchiolitis VRS |
|
Intravenous
palivizumab in VRS |
Whole blood gene expression in infants with
VRS |
|
Bronchiolitis requiring oxygen therapy in February 2020 |
Host gene signatures for diagnosis of infectious diseases |
|
Risk of wheeze and asthma after
VRS infection |
Immune profiles into VRS disease severity in children |
|
Impact of Coronavirus on Hospitalizations for VRS |
The journey to a
respiratory syncytial virus vaccine |
|
|
|